Aurora Spine launches Dexa-L fusion device

Mr. Trent Northcutt reports AURORA SPINE ANNOUNCES LAUNCH OF ITS DEXA-L ANTERIOR LUMBAR INTERBODY FUSION DEVICE Aurora Spine Corp. has officially launched its Dexa-L anterior lumbar interbody fusion device, with the product being implanted in recent initial surgeries. Dexa-L is part of Aurora's patented Dexa technology platform, which is a series of products that are the world's first bone density matched implants. The Dexa-L, part of the Dexa technology platform, is a stand-alone device for anterior lumbar interbody fusion procedures and is the first of its kind in the world. It is the first spinal implant that is a bone-mimicking structural implant helping doctors match the implant to the patient's bone density and quality. Dr. Daniel Barba of San Diego, Calif., was the first surgeon to use the Dexa-L stand-alone ALIF system in the United States. Dr. Barba stated: "Each of my patients are unique. I build a tailored surgical plan for every patient. Now I can use a stand-alone ALIF cage tailored specifically to their needs. This novel technology allows me to match the modulus of the cage to the bone density of each of my patients. This has enabled me to expand my indications for lumbar fusion within patients that would normally not be a good candidate due to their poor bone quality. We don't accept one size fits all in today's society. We as spine surgeons shouldn't either." Ron Eckels, U.S. director of spine with Aurora Spine, stated: "Today's release of the Aurora Spine Dexa-L stand-alone ALIF system, promoting bone density matched Dexa technology, marks another landmark advancement for spinal surgery from Aurora Spine. We are excited to introduce another procedural solution that accommodates not only standard spine patients but the most challenging patients who are also in need of care. Patient specific options for spine surgery have been advancing over the last several years, but not matching a patient's bone density was a glaring need for a significant number of patients. The CDC estimates that almost half of the U.S. population over 50 years of age have low bone mass. This equates to millions of patients that need an implant that matches their bone density when having spine surgery. The Dexa-L stand-alone ALIF system now allows surgeons the opportunity to treat patients who have osteopenia or osteoporosis, as well as those who have normal bone density but still need surgery. The days of not matching an implant modulus to the patient are behind us." "Today we're introducing Dexa-L, the world's first anterior lumbar stabilization system engineered to match each patient's bone quality," said Laszlo Garamszegi, chief technology officer of Aurora Spine. "Powered by our patented Dexa technology and building on the momentum of Dexa-C, our cervical fusion implant utilized in numerous institutions throughout the United States, Dexa-L provides a stand-alone ALIF option for patients with less-than-optimal bone quality. Importantly, this technology could lead to less subsidence, as observed in internal testing of our cervical platform, bringing the same patient-specific approach to the lumbar spine." About Aurora Spine Corp. Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of proprietary, minimally invasive and regenerative technologies. The company is committed to improving surgical outcomes through innovation, efficiency and patient-centred design. We seek Safe Harbor.